Valdecoxib

伐地考昔

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameValdecoxib
Drug Alias Name戊地昔布valdecoxibvaldecoxibum伐地昔布代他考昔 +[14
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2
Therapy Area/IndicationsPainPain, PostoperativeDysmenorrhea +[9
Global Approved IndicationsDysmenorrheaOsteoarthritisArthritis, Rheumatoid
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2001/11/16
Country/TerritoryCanadaUnited StatesIndia +[5
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsPainPain, PostoperativeDysmenorrhea +[9

Other Information

ATC CodeM01AH03